Literature DB >> 17017377

Occupational asthma.

Cristina E Mapp1, Deborah Miotto, Piera Boschetto.   

Abstract

Occupational asthma (OA) is one of the most common forms of occupational lung disease in many industrialized countries, having been implicated in 9 to 15% of adult-onset asthma. Work-related asthma includes: 1. immunologic OA, characterized by a latency period before the onset of symptoms; 2. nonimmunologic OA, which occurs after single or multiple exposures to high concentrations of irritants; 3. work-aggravated asthma, which is pre-existing or concurrent asthma exacerbated by workplace exposures; and 4. variant syndromes. OA is important to recognize clinically, because it has serious medical and socioeconomic consequences. Diagnosis of OA should be confirmed by objective testing early after its onset. Removal of the worker from exposure to the causal agent and early treatment with anti-inflammatory drugs lead to a better outcome. Assessment of the work environment and identification of host factors may provide us with useful information about the mechanisms involved in OA. Another issue concerns strategies for preventing OA which should be implemented.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17017377

Source DB:  PubMed          Journal:  Med Lav        ISSN: 0025-7818            Impact factor:   1.275


  2 in total

1.  Aerosolized Red Tide Toxins (Brevetoxins) and Asthma: Continued health effects after 1 hour beach exposure.

Authors:  Barbara Kirkpatrick; Lora E Fleming; Judy A Bean; Kate Nierenberg; Lorraine C Backer; Yung Sung Cheng; Richard Pierce; Andrew Reich; Jerome Naar; Adam Wanner; William M Abraham; Yue Zhou; Julie Hollenbeck; Daniel G Baden
Journal:  Harmful Algae       Date:  2011-01-01       Impact factor: 4.273

2.  Response to oyster mushroom (Pleurotus ostreatus) extract by sensitized and nonsensitized guinea pig trachea.

Authors:  E N Schachter; E Zuskin; J Pucarin-Cvetkovic; A Chiarelli; S Goswami
Journal:  Lung       Date:  2011-06-12       Impact factor: 2.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.